CNS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.
CEOJohn M. Climaco
CEOJohn M. Climaco
Employees5
Employees5
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2017
Founded2017
Employees5
Employees5
CNSP Key Statistics
Market cap4.71M
Market cap4.71M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume45.88K
Average volume45.88K
High today$8.33
High today$8.33
Low today$7.58
Low today$7.58
Open price$7.66
Open price$7.66
Volume48.27K
Volume48.27K
52 Week high$320.88
52 Week high$320.88
52 Week low$7.50
52 Week low$7.50
People also own
Based on the portfolios of people who own CNSP. This list is generated using Robinhood data, and it’s not a recommendation.